GlassScriptPhysician profile
Virginia Cottrell Howell
NPI 1295364180
$600.21
in general payments reported to CMS, 2019-2025
15 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $224 · 2024: $136 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $156.09 | 2023-2025 | Accrufer |
| Abbvie INC. | $68.29 | 2023-2025 | |
| Hologic Sales and Service, LLC | $51.99 | 2023-2025 | Aptima |
| Lilly USA, LLC | $51.67 | 2024-2025 | Zepbound |
| Astellas Pharma US INC | $38.32 | 2025 | Veozah |
| Sage Therapeutics, LLC | $37.42 | 2024 | |
| Axonics, INC. | $37.25 | 2023 | Axonics |
| Exact Sciences Corporation | $32.59 | 2023-2024 | Cologuard Collection Kit |
| Ibsa Pharma INC. | $21.48 | 2023 | Tirosint, Licart |
| Exeltis, USA INC. | $19.25 | 2023 | Slynd |
| Novo Nordisk INC | $19.08 | 2025 | Wegovy |
| Organon LLC | $18.36 | 2023 | Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $18.01 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $15.70 | 2023 | Livalo, Seglentis |
| Amgen INC. | $14.71 | 2025 | Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.